• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    BioVersys Gets EIB Funds to Address Antimicrobial Resistance

    Microbiologics Expands Virology Services

    ATMPS, Ori Biotech Integrate Digital Platform for Cell & Gene Therapies

    Executive Moves: Novavax

    Albumedix Completes Commercial-Scale Mfg. Facility Expansion
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Albumedix Completes Commercial-Scale Mfg. Facility Expansion

    Ensuring Pharma Manufacturing Quality

    Exploring ICP-MS expertise at Almac

    Catalent Biologics Completes Madison Expansion

    Ascendia Pharmaceuticals Poised for Expansion
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!

    Securing Your API Supply Chain: Three Keys to Success

    Enteris BioPharma: Custom Solutions – From Bench to Market

    The Benefits of Outsourcing Cold Storage
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    BioVersys Gets EIB Funds to Address Antimicrobial Resistance

    Microbiologics Expands Virology Services

    ATMPS, Ori Biotech Integrate Digital Platform for Cell & Gene Therapies

    Albumedix Completes Commercial-Scale Mfg. Facility Expansion

    Exploring ICP-MS expertise at Almac
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Ensuring Pharma Manufacturing Quality

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations

    Enteris BioPharma: Custom Solutions – From Bench to Market
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Quotient Sciences

    Almac Group

    PCI Pharma Services

    Baxter BioPharma Solutions

    Aphena Pharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Aphena Pharma Solutions

    Syngene

    Quotient Sciences

    Emergent BioSolutions

    Baxter BioPharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Successful Serialization Partner Selection

    Can speed, business value and total cost of ownership exist in the same space when compliance cannot wait?

    Successful Serialization Partner Selection
    Related CONTENT
    • Ensuring Pharma Manufacturing Quality
    • Vetter Packaging Solutions
    • Vetter Commercial Manufacturing
    • Imvax Appoints Sean Hemingway Chief Operating Officer
    • Legacy Pharma Solutions Appoints President
    Michael Howe, CEO, Verify Brand03.07.17
    November 2017 is rapidly approaching and with it, the deadlines for the Drug Supply Chain Security Act (DSCSA). As pharmaceutical contract manufacturing organizations (CMOs) and re-packagers and third-party logistics (3PL) providers check the final boxes before implementing serialization, there are a number of considerations to address during vendor selection.

    Each company is at a unique place in this process. Some have already implemented serialization while others are still struggling to understand what to look for in a partner or platform. With a priority on fast implementation and compliance, it’s important not to lose sight of other factors critical to long-term success, namely total cost of ownership and value to the business.

    Fast-turn implementation
    If you fall in the category of “still deciding,” one of the first questions you need to ask your serialization partner is “how long will this take?” Depending on your existing systems, serialization isn’t just one project—it’s a series of changes that include evaluating partner systems and integration points, modifying packaging lines, rolling out software, completing hardware validations, training staff and more.

    When evaluating partners, talk to each of them about the timelines of similar companies with equivalent volumes, foundational software and hardware systems, or partners. Then back out your own timeline, leaving room for testing and training.

    If your potential partner only offers visibility into their own part of the process, they probably won’t provide any assistance when it comes to optimizing your partner networks or getting reports that consolidate data across systems. While they may advertise what appears to be a “fast turn” implementation, make sure that you take all other factors into account.

    A more realistic approach is to find a partner that creates true end-to-end visibility across your supply chain and is experienced guiding companies through the entire serialization data exchange process. In addition, a partner that has experience implementing serialization across both pharma and non-pharma environments will be able to offer unique solutions that are customized to your business. They aren’t going to try to negotiate you into an off-the-shelf pharma solution.

    If a partner promises a timeline that seems too good to be true, don’t be afraid to challenge it. Chances are they are only looking at their role, and not taking into account all the steps required to meet your goal.

    Managing total cost of ownership
    Managing any project for total cost of ownership (TCO) can be complicated, especially if you don’t understand or have visibility into all the moving parts. This is another area where your serialization partner can be a huge asset.

    First, pharma companies should strive for clarity when evaluating serialization platforms. Focus on the terminology used with each platform. For example, there’s a major difference between an “on-premise” and a “single tenant” platform. With an on-premise model, the entire solution resides within the pharma brand’s enterprise, which can increase the infrastructure costs for the business. However, in a single-tenant model, the solution is hosted and supported by the service provider, so there are no costs for hardware, maintenance or solution management.

    Another method to keep in mind to avoid hidden costs is to ask your most challenging technology questions early in the process. During the proposal phase, it is vital to inquire and confirm that the partner can describe all technology-related fees that might not be top-of-mind, including partner on-boarding fees, charges per serial number and user administration and system monitoring fees. For example, if you are considering customizations to the platform, ask your potential partner if they charge professional services fees every time you customize components of the application. Ensuring a flexible and configurable architecture is your end goal, so it’s important to know how these incremental costs may impact your ability to modify the system in the future. 

    Working with potential providers to determine partner and network capacity and integrations can also involve fees. Will their solution work with your organization over time as you add or modify integrations? The answer to all these questions will impact the platform TCO, so pay attention to how vendors answer these questions.

    Determining associated costs for support, training and upgrades will also define the right platform for your business, and can also help you manage whether your investments are focused upfront or will continue to build up over time. 

    For example, with some platforms, the serialization provider dictates the time and number of ongoing software upgrades. This means that any associated validation costs for the system are entirely up to you, but you’re bound to the serialization provider’s schedule. Not being able to manage your own upgrade and re-verification schedule can drive up costs for staffing and impact productivity.

    It is also important to remember that avoiding excessive TCO is a two-sided equation. It’s easy for companies to focus on calculating the costs, but don’t forget about the savings. Using a serialization solution that will save you money throughout your entire business is going to provide the ideal, long-term TCO.

    Value beyond compliance
    Yes, compliance is the end goal. But why give up future business value just to get something implemented quickly? You can have both—and it won’t take you any longer to find and implement than compliance alone. 

    Serialization impact goes well beyond track-and-trace and keeping stock of item and lot-level packages. It can provide insights into item-level data that not only helps keep track of saleable units but also reduces potential losses and process inefficiencies.

    For example, with precise track-and-trace data, we can now understand the exact number of salable units produced on any given day, within a specific range of hours and on any production line. Insights can also be generated for dwell time or the time it takes to get items through a location, allowing for greater decision-making on how quickly product moves through the supply chain. Insights also help identify possible bottlenecks in the process.

    A serialization platform can help you understand item-loss disbursement due to quality issues and general process inefficiencies to focus on reducing these problems directly in your supply chain and partner network.

    As you are identifying a serialization platform for compliance, ask them how they’ll create value after you check that compliance box. Have them describe their efficient and transparent implementation process that helps you connect your entire organization to meet compliance requirements but also drive efficiency throughout your supply chain.

    With the right partner and platform, you’ll get everything you need: compliance, simplified integrations and the building blocks for a platform that can set your business up for future enhancements and better business insights.

    It’s a team decision
    As you review all the elements that go into making a serialization decision, don’t forget that this isn’t a decision most companies make separate from your trading partners. Because DSCSA requires all companies along the drug supply chain to ensure traceability of products within their operations, it’s often necessary to audit all potential integrations along the chain to determine how you’ll create end-to-end visibility, traceability and compliance. So what do you need understand to make an informed decision?

    Each of your pharma clients and trading partners will expect to receive data from the tracking events you capture. Conversely, you may need to accept or receive data from them.
    So, the most important thing to understand is the content of the data that needs to be exchanged with trading partners. Questions to ask your partners include:
    • Exactly what critical, tracking-event data do they expect to receive from you? Then consider how this compares to the data you plan to capture and make adjustments as necessary;
    • Do you and your trading partners have agreement on the identifiers to be used in the data? For example, are you all using serialized global trade item numbers for product identification and global location numbers for party and location identification?; and
    • What master data needs to be synchronized with each partner? Required master data might include trade item attributes, such as drug name, dosage form and dose. Required party and location master data usually includes name and address information.
    Bear in mind that your partners may also be at an early stage of understanding their own requirements. It is essential to dig deeply and question whether your partners are providing all the necessary detail so there are no surprises as you get closer to the deployment deadline.

    After agreeing on data content, there are a number of more technical issues that have to be addressed in order to achieve smooth interoperability with partners. A common theme is adherence to widely accepted industry data standards, especially if you are interfacing with multiple partners.

    Don’t assume that your IT systems and partner systems will interoperate—it’s important to prove this through testing. With limited time left to implement and test systems, the more you can prepare by understanding the systems involved, the faster you can get to the testing stage.

    The role of data standards
    We’ve shown that it’s possible to find the right serialization solution that offers fast implementation relative to your existing system and needs, meets your TCO goals, and provides value above and beyond compliance. So, is that all there is to consider?

    Not quite. Another important consideration for your platform is the role of data standards. One of the most challenging elements of any serialization project is effectively managing integration points with partners, such as contract manufacturers, 3PL or government agencies. Successful integrations rely on the ability to connect and align various networks seamlessly, which makes data standards important.

    GS1’s EPCIS standards allow pharma companies to communicate with trading partner networks. GS1 members continually work to improve the standards as newer regulations are put in place around the world.

    Leveraging the GS1 EPCIS standard is critical for efficient and optimal integration among partners and customers. But not every provider has the ability or the willingness to support these common technology standards and will lead you to believe that standards are a “nice to have.”

    With the mountains of data collected through serialization, having a partner that can compile and translate data into meaningful insights is key to creating knowledge within your organization. This is much more than a “nice to have,” in fact it’s becoming a critical part of a company’s ability to compete and gain market share.

    As you interact and communicate with network partners, it also requires end-to-end visibility. Having a serialization platform that does not use a common data-exchange language can reduce visibility throughout the supply chain and leave you open to risk that you cannot see.

    Standards are critical. These standards provide a common environment where the platform can analyze and pull meaningful insights that can later be shared throughout the network, increasing both upstream and downstream communication. Identifying a serialization partner that can leverage EPCIS standards, including recent updates (e.g., version 1.2), will provide short-term benefits and reduce potential problems down the road.

    So, be mindful of platforms and partners that don’t support and deploy standards-based solutions, as they can increase integration and TCO as you and your partner work to maintain efficient integrations across networks that don’t speak the same language.

    While it is not required to follow standards, leveraging standards can increase your business’s competitive edge relative to other companies that are limited to basic connection points. Insights rather than connectivity is the real value from serialization and a critical component for building an intelligent supply chain.

    Reducing complexity and focusing on quality
    Meeting the upcoming DSCSA guidelines is a challenging endeavor for pharma companies and their partners throughout the supply chain. Not only do companies need to select the right partner, there are important costs and benefits to discuss before implementation.

    Selecting the right platform is a combination of partner experience, price and determining the right integration approach for your current and future business needs. There is no one-size-fits-all platform. Using the right standards that produces impactful insights will help you meet compliance and extend value throughout your entire organization. The modern supply chain is often complex, and many companies wonder if serialization will equally require a complex and difficult-to-understand platform. That’s not always true. Working with your serialization partner to discuss network and supply-chain capabilities will ensure that in addition to creating value up and down the supply chain, you check the compliance box along the way.

    Another critical consideration is eliminating the hidden costs and reducing your overall TCO. Asking the right questions before you implement a solution can save time and money as you begin the process.

    Time is ticking on the DSCSA compliance clock. Whether you have already selected your partner or are still in the hunt, it is important to actively engage with potential vendors to determine that they will help you reach compliance and also prepare you for growth and success in the future. 


    Michael Howe is chief executive officer for Verify Brand. As a pioneer in creating disruptive innovations, Michael leverages his decades of experience with Fortune 100 companies and other leading brands to help pharma companies integrate serialization technology to drive business growth.
    Related Searches
    • it
    • supply chain
    • serialization
    • track-and-trace
    Suggested For You
    Ensuring Pharma Manufacturing Quality Ensuring Pharma Manufacturing Quality
    Vetter Commercial Manufacturing Vetter Commercial Manufacturing
    Vetter Packaging Solutions Vetter Packaging Solutions
    Imvax Appoints Sean Hemingway Chief Operating Officer Imvax Appoints Sean Hemingway Chief Operating Officer
    Legacy Pharma Solutions Appoints President Legacy Pharma Solutions Appoints President
    Cryoport Acquires Critical Transport Solutions Australia Cryoport Acquires Critical Transport Solutions Australia
    Rentschler Biopharma Names Martin Kessler as New CEO in U.S. Rentschler Biopharma Names Martin Kessler as New CEO in U.S.
    EMA Approves BioNTech EMA Approves BioNTech's COVID Vax Production at Marburg Site
    Fast Track Automation in Pharmaceutical Manufacturing Fast Track Automation in Pharmaceutical Manufacturing
    Catalent Expands Partnership with J&J Catalent Expands Partnership with J&J
    PCI Pharma Services Expands Cold Chain Clinical Supply Storage PCI Pharma Services Expands Cold Chain Clinical Supply Storage
    Metrics Contract Services Completes Russian Regulatory Inspection Metrics Contract Services Completes Russian Regulatory Inspection
    Baxter Biopharma Enters Sterile Manufacturing Agreement for Novavax’ COVID-19 Vaccine Baxter Biopharma Enters Sterile Manufacturing Agreement for Novavax’ COVID-19 Vaccine
    Sharp Appoints EU Qualified Person Sharp Appoints EU Qualified Person
    Injectable Drug Delivery Trends Injectable Drug Delivery Trends

    Related Features

    • R&D
      Small Innovators & Niche CROs

      Small Innovators & Niche CROs

      Smaller CROs have the opportunity to provide a niche approach to its clients, particularly smaller sponsors who have shared synergies.
      Neil Goodman, David Bruce and Mohamed El Malt, Europital 04.01.21

    • Laboratory Testing
      Focus on Science

      Focus on Science

      How to maximize lab performance and value through comprehensive equipment management.
      Rohit Shroff, Senior Vice President, Global Lab Products, Avantor 04.01.21

    • Analytical Services | Bioanalytical Services | Laboratory Testing | R&D
      Rapid and Data Rich Chromatographic Method Development

      Rapid and Data Rich Chromatographic Method Development

      An overview of what to consider when developing chromatographic methods.
      Daniel Kirschner, Executive Director of Analytical Services, Cambrex - Durham, North Carolina 04.01.21


    • Preparing Your Post Pandemic Talent Strategy

      Preparing Your Post Pandemic Talent Strategy

      Areas for consideration for adopting the right approach to reinforce investments, optimize business and maximize your workforce.
      Neil Kelly, Managing Partner, Vector Partners 04.01.21

    • Laboratory Testing | R&D
      How Modern Near-Infrared Came to Be

      How Modern Near-Infrared Came to Be

      First region outside the visible to be discovered and last to be utilized.
      Gary E. Ritchie, Contributing Writer 04.01.21

    • APIs | Supply Chain
      Securing Your API Supply Chain: Three Keys to Success

      Securing Your API Supply Chain: Three Keys to Success

      Key considerations when outsourcing API procurement and supply chain management.
      Selwyn Lustman and Lina Cogan, LGM Pharma 04.01.21


    • Solid Dosage/Semi-solids
      Hygienic Packaging Technology

      Hygienic Packaging Technology

      Growing consumer demand for health products highlights hygienic packaging.
      John Brown, Vice President of Global Marketing, Selig 03.01.21

    • Drug Delivery | Solid Dosage/Creams/Ointments
      Trends in Solid Oral Dosage Delivery

      Trends in Solid Oral Dosage Delivery

      Capsule demand continues to rise due to this delivery system’s versatility.
      Anita Solanki, Milind Biyani and Jnanadeva Bhat, PhD , ACG Capsules 03.01.21

    • Information Technology
      5 Reasons Paper Has No Place in Contract Manufacturing

      5 Reasons Paper Has No Place in Contract Manufacturing

      Digital solutions create more efficient manufacturing processes and eliminate delays.
      Dave Edwards, Chief Revenue Officer, MasterControl 03.01.21


    • Drug Delivery | Parenterals
      Injectable Drug Delivery Trends

      Injectable Drug Delivery Trends

      How medication trends are driving the shift to patient-friendly drug delivery systems.
      Peter Soelkner, Managing Director, Vetter 03.01.21

    • Pharmaceutical Manufacturing  Equipment Trends

      Pharmaceutical Manufacturing Equipment Trends

      Demand for flexibility remains the driving force behind equipment systems.
      Kristin Brooks, Managing Editor, Contract Pharma 03.01.21

    • Drug Delivery | Solid Dosage/Creams/Ointments
      Oral Solids:   Market & Technology Trends

      Oral Solids: Market & Technology Trends

      Oral solids remain the preferred route of drug delivery due to their cost-effectiveness, ease of manufacturing, and patient-friendly dose form options.
      Tim Wright, Editor, Contract Pharma 03.01.21


    • Nutraceutical Manufacturing:  Meeting the Challenges of Today, Planning for  Tomorrow

      Nutraceutical Manufacturing: Meeting the Challenges of Today, Planning for Tomorrow

      Companies continue balancing high demand, supply disruption, and worker safety during the pandemic.
      Sean Moloughney, Editor, Nutraceuticals World 03.01.21

    • 2021 Contract  Manufacturing Survey

      2021 Contract Manufacturing Survey

      Our fourth annual audience poll indicates continued reliance on manufacturing partners, particularly for small businesses.
      Sean Moloughney, Editor, Nutraceuticals World 03.01.21

    • APIs
      Small Molecule Development Trends

      Small Molecule Development Trends

      A Q&A with Cambrex Edinburgh’s site director, Mark Benger.
      Tim Wright, Editor, Contract Pharma 03.01.21

    Trending
    • Astellas, Affinivax In Global MAPS Vax Pact
    • Ascendia Pharmaceuticals Poised For Expansion
    • Executive Moves: Novavax
    • Ensuring Pharma Manufacturing Quality
    • Sanofi Invests In Cutting Edge Vax Production Site In Singapore
    Breaking News
    • BioVersys Gets EIB Funds to Address Antimicrobial Resistance
    • Microbiologics Expands Virology Services
    • ATMPS, Ori Biotech Integrate Digital Platform for Cell & Gene Therapies
    • Executive Moves: Novavax
    • Albumedix Completes Commercial-Scale Mfg. Facility Expansion
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    BIO-CAT Microbials’ OPTI-BIOME Probiotic Strain Receives FDA “Letter of No Objection” on GRAS Status
    6th Annual Dietary Supplements Regulatory Summit Scheduled for July 13
    Bunge Invests $47.5 Million in Australian Plant Proteins
    Coatings World

    Latest Breaking News From Coatings World

    Jebsen & Jessen, Innospec Sign Distribution Agreement
    VideoBite: Engineered Polymer Solutions
    Shepherd Color Unveils Bismuth Vanadate Yellow Pigment
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Medtronic Introduces Extended Infusion Set in Europe
    BioSig Launches Software Update for PURE EP Electrophysiology Platform
    Katena Acquires Ophthalmic Surgical Instrument Maker ASICO
    Contract Pharma

    Latest Breaking News From Contract Pharma

    BioVersys Gets EIB Funds to Address Antimicrobial Resistance
    Microbiologics Expands Virology Services
    ATMPS, Ori Biotech Integrate Digital Platform for Cell & Gene Therapies
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Cosmoprof Worldwide Bologna Postpones 2021 Show
    Native Launches Broad Spectrum SPF 30 Mineral Sunscreens
    Revieve Launches Skin Coach
    Happi

    Latest Breaking News From Happi

    Hallstar Beauty Names New President
    The Fragrance Foundation Announces the 2021 Awards Finalists
    Azelis Earns 'Coup de Coeur' Award at Cosmetagora 2021
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Epson SurePress reaches milestone
    Maxcess updates user interface for Fife guiding Sensor
    Bobst announces virtual packaging industry event
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    PCMC Redesigns Rx200 and Mako Clipper Wet Wipes Machines
    PFNonwovens Adding New Capabilities in Znojmo
    Russ Torres Named Group President of Kimberly-Clark North America
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Biogennix Rolls Out Agilon Strip Bone Graft
    Global Bone Tumor Ablation Devices Market to Top $111 Million by 2027
    GreenBone Ortho Closes 10 Million Euros Series B Funding Round
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence
    European Commission's Innovation Radar Acknowledges 3 ARMOR Innovations
    SUPERSMART Wins 'Best Publicly Funded Project Demonstrator' in 2021 OE-A Competition

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login